|
Tue, 10/08/2024 - 07:21 |
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program |
OPKO |
|
Sat, 05/25/2024 - 00:37 |
Children exposed to SARS-CoV-2 in womb or as newborns may face increased social and respiratory problems, finds study |
University of B... |
|
Tue, 07/26/2022 - 18:05 |
Scientists confirm COVID tied to wildlife sales at Chinese market |
UCLA |
|
Tue, 07/26/2022 - 17:24 |
Pair of studies illuminates COVID-19 pandemic origins |
Scripps Research |
|
Thu, 06/30/2022 - 03:05 |
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus |
bd |
|
Tue, 04/19/2022 - 20:30 |
Huateng Pharma Supplies Ensitrelvir Intermeidates Against COVID-19 |
Hunan Huateng P... |
|
Wed, 03/23/2022 - 12:24 |
Face Masks and Other Prevention Strategies |
American Academ... |
|
Thu, 03/17/2022 - 15:28 |
Texas Biomed and partners discover new, potent COVID-19 antibody cocktail |
Texas Biomed |
|
Tue, 03/15/2022 - 18:01 |
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19 |
Scripps Research |
|
Thu, 03/03/2022 - 00:01 |
Nirsevimab significantly protected infants against RSV disease in Phase 3 trial |
Sanofi |
|
Tue, 01/11/2022 - 16:56 |
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2022 at the 40th Annual J.P. Morgan Healthcare Conference |
Enanta Pharmace... |
|
Fri, 12/31/2021 - 00:13 |
Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-235, its Oral 3CL Protease Inhibitor Specifically Designed for the Treatment and Prevention of COVID-19 |
Enanta Pharmace... |
|
Tue, 12/21/2021 - 17:04 |
Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization |
Johns Hopkins H... |
|
Thu, 12/16/2021 - 05:56 |
NIH scientists urge pursuit of universal coronavirus vaccine |
NIH |
|
Mon, 11/29/2021 - 19:37 |
Natural COVID-19 infections protect against SARS-CoV-2, gamma and delta variants |
University of M... |
|
Fri, 10/15/2021 - 05:03 |
One coronavirus vaccine may protect against other coronaviruses |
Northwestern Un... |
|
Fri, 10/15/2021 - 01:32 |
Confirmed High Levels of SARS-CoV-2 Virus in Children |
Ragon Institute |
|
Thu, 09/23/2021 - 16:31 |
COVID-19 Spurred Mitra Microsampling Innovation in Bioanalysis |
Neoteryx |
|
Sun, 09/19/2021 - 20:36 |
Successive COVID-19 Variants Becoming More Airborne, Researchers Find |
UniversityofMaryland |
|
Wed, 09/15/2021 - 06:09 |
NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19 |
NIH |
|
Sun, 09/05/2021 - 21:14 |
Top news stories from AMA Morning Rounds: Week of Sept. 6, 2021 |
AMA |
|
Wed, 09/01/2021 - 12:53 |
Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection |
Merck |
|
Thu, 08/19/2021 - 19:03 |
Hundreds of millions of Africans lack basic means of preventing SARS-CoV-2 transmission, finds global study |
University of B... |
|
Thu, 08/12/2021 - 21:55 |
Researchers Continue to Zero in on How COVID-19 Spreads |
UniversityofMaryland |
|
Fri, 08/06/2021 - 17:40 |
Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, reveals study |
University of B... |
